| View |
2021-10-21-0501
|
HEPATITIS B VACCINE (rDNA)
|
GENVAC-B
|
BR-567
|
0321Q004E
|
Packaging Lot (Box & Vial): 0321Q004E
|
30 April 2024
|
25 October 2021
|
| View |
2022-02-14-0036
|
LIVE ATTENUATED ROTAVIRUS VACCINE
|
ROTARIX
|
BR-674
|
AROLD251A
|
Packaging Lot (Box & PFS): AROLD251AG
|
30 April 2024
|
17 February 2022
|
| View |
2022-03-04-0054
|
RECOMBINANT HEPATITIS B VACCINE
|
ENGERIX-B
|
BR-744
|
AHBVD027A
|
Packaging Lot (Box & PFS): AHBVD027AP; (Needle): 2104014
|
30 April 2024
|
8 March 2022
|
| View |
2022-05-11-0104
|
RECOMBINANT HEPATITIS B VACCINE
|
ENGERIX-B
|
BR-744
|
AHBVD023A
|
Packaging Lot (Box & PFS): AHBVD023AO; (Needle): 2106012
|
30 April 2024
|
12 May 2022
|
| View |
2022-05-17-0114
|
HEPATITIS A (INACTIVATED) AND HEPATITIS B (RDNA) (HAB) VACCINE (ADSORBED)
|
TWINRIX ADULT
|
BR-404
|
AHABB443A
|
Packaging Lot (Box): AHABB443 AI; (Syringe): AHABB443 AI; (Needle 23G x 1''): 2106012
|
30 April 2024
|
23 May 2022
|
| View |
2022-07-29-0207
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822019
|
Packaging Lot (Box & Vial): A06822019
|
30 April 2024
|
2 August 2022
|
| View |
2022-07-29-0208
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822016
|
Packaging Lot (Box & Vial): A06822016
|
30 April 2024
|
3 August 2022
|
| View |
2022-07-29-0209
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822015
|
Packaging Lot (Box & Vial): A06822015
|
30 April 2024
|
2 August 2022
|
| View |
2022-09-14-0252
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822022
|
Packaging Lot (Box & Vial): A06822020
|
30 April 2024
|
21 September 2022
|
| View |
2022-09-14-0253
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822021
|
Packaging Lot (Box & Vial): A06822023
|
30 April 2024
|
19 September 2022
|
| View |
2022-09-14-0254
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822020
|
Packaging Lot (Box & Vial): A06822020
|
30 April 2024
|
19 September 2022
|
| View |
2022-10-14-0292
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06822018
|
Packaging Lot (Box & Vial): A06822018
|
30 April 2024
|
18 October 2022
|
| View |
2022-10-24-0315
|
BACILLUS CALMETTE-GUERIN, LIVE VACCINE
|
SII-ONCO-BCG
|
BR-851
|
1132G023
|
Packaging Lot (Box & Vial): 1132G023
|
30 April 2024
|
28 October 2022
|
| View |
2022-10-18-0301
|
TYPHOID POLYSACCHARIDE VACCINE
|
TYPBAR
|
BR-827
|
54D22004A
|
Packaging Lot (Box & PFS): 54D22004A; (Needle): 2001057
|
30 April 2025
|
21 October 2022
|
| View |
2021-08-10-0392
|
RITUXIMAB
|
MABTHERA
|
BR-1141
|
H1066
|
Packaging Lot (Box): H1066B04
|
30 August 2023
|
13 August 2021
|
| View |
2020-08-28-0229
|
Purified Rabies Vaccine (Vero Cell)
|
Speeda
|
BR-669
|
201912454
|
Packaging Lot (box & vial): 201912454; (diluent): 28190905-2 MD: 31 DEC 2019 ED: 30 DEC 2022
|
30 December 2022
|
02 September 2020
|
| View |
2021-03-15-0117
|
Insulin Human (rDNA)
|
INSUGET-R
|
BR-1103
|
124P03
|
Packaging Lot (Box & Vial): 124P03
|
30 December 2022
|
17 March 2021
|
| View |
2021-04-27-0184
|
EMICIZUMAB
|
HEMLIBRA
|
BR-1331
|
B3004
|
Packaging Lot (Box): B3004B14; (Vial): B3004
|
30 December 2022
|
30 April 2021
|
| View |
2021-04-27-0185
|
EMICIZUMAB
|
HEMLIBRA
|
BR-1332
|
B3003
|
Packaging Lot (Box): B3003B38
|
30 December 2022
|
30 April 2021
|
| View |
2020-05-15-0123
|
Quadrivalent Seasonal Influenza Vaccine (Inactivated, Type A & B) 2020 Southern Hemisphere Strain
|
Fluquadri
|
BR-1084
|
U6869
|
Packaging Lot: Box & PFS: UJ395AA; Needle (25G x 5/8): 9203650 (MD: 2019-08; ED: 2024-04)
|
30 January 2021
|
18 May 2020
|